Clinical trials recruiting for Breast Cancer (Locally Advanced or Metastatic)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Dual-target CAR-NK cells (EB-DT-CAR-NK) | 1 |
| EBNK-001 + IL-15 + Pembrolizumab | 1 |
| INV-6452 | 1 |
| Lymphodepleting chemotherapy | 1 |
| SH009 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
- Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Remote Monitoring and Symptom Management Digital Application
- Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer
Related conditions
Trials recruiting for Breast Cancer (Locally Advanced or Metastatic) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Cancer (Locally Advanced or Metastatic) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.